logo
GSK makes new drug submission for depemokimab in Canada

GSK makes new drug submission for depemokimab in Canada

Yahoo27-05-2025
GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific conditions.
The first proposed indication is for the use as an add-on maintenance treatment for asthma in individuals aged 12 years and above with type 2 inflammation marked by an eosinophilic phenotype.
The second is for treating adults with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP).
Depemokimab targets interleukin-5 (IL-5), which plays a crucial role in type 2 inflammation.
GSK's submission is supported by the positive Phase III SWIFT and ANCHOR trial data.
These trials have demonstrated that the antibody could provide sustained inhibition of a key disease driver and assist in achieving clinical outcomes with two injections annually.
The extended half-life and binding affinity of the antibody support a dosing regimen of a single injection every six months.
Patients with CRSwNP often suffer from symptoms such as loss of smell, facial pain, nasal obstruction, sleep disturbance, nasal discharge and infections.
The effectiveness and safety of the antibody are still being investigated, and it has neither been granted any authorisation nor approved for use in any nation at present.
GSK Canada country medical director Michelle Horn stated: 'The combined submission for asthma and CRSwNP marks a significant step toward addressing the unmet needs of patients.
'Backed by strong clinical evidence, depemokimab has the potential to become the first ultra-long-acting biologic offering patients sustained inhibition of IL-5, a key driver of their disease with twice-yearly dosing, and represents a promising advancement for patients and physicians alike.'
In November 2024, GSK secured Health Canada's approval for Ojjaara (momelotinib) to treat myelofibrosis in adults with moderate-to-severe anaemia.
"GSK makes new drug submission for depemokimab in Canada" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Taylor Swift shares update on dad's health after heart surgery

time12 minutes ago

Taylor Swift shares update on dad's health after heart surgery

Taylor Swift is sharing an update on her dad Scott Swift's and mom Andrea Swift's health. The pop superstar opened up about her parents in Wednesday's podcast episode of "New Heights," which is hosted by Swift's boyfriend Travis Kelce and his older brother Jason Kelce. Swift said her 73-year-old father is recovering following what she described as a "really intense" heart surgery in Florida earlier this summer. "He's doing good," Swift said. "He is doing incredibly well. My dad had an interesting summer. He actually had a quintuple bypass surgery, and that's a really intense surgery." The 35-year-old said that her dad previously had "perfect" electrocardiogram or EKG tests, a type of test doctors use to measure the electrical activity, rate, and regularity of a person's heartbeat, which they use to help diagnose heart conditions, according to the Centers for Disease Control and Prevention. However, Swift said her dad subsequently went in for a nuclear stress test -- an imaging test in which stress is induced through exercise or pharmacologic agents to view how blood flows through the heart, according to StatPearls, an online library published in the National Library of Medicine -- and doctors found reduced blood flow in five areas in his heart that needed to be treated quickly. Swift said her dad's major surgery brought their family, including her mom and brother Austin, closer and that they "all moved in with him for the whole summer," helping him both in and out of the hospital, an experience she called both "special" and "surreal." "He came out of surgery, tried to give guitar picks to all the nurses and doctors, but he wasn't wearing pants. Didn't have pockets, hospital gown," Swift recalled. "I'm having these moments where I'm like, this dude built play sets and swing sets and cribs for me. I'm building his … shower chair and his walker ... Like, it's just surreal, man." Swift also revealed that her mom also underwent surgery recently, getting a knee replacement. "My mom just got a new knee. She's doing great," Swift said. "This was just, like, the summer of my parental upgrades. We're just upgrading the parents, making sure that they live to be at least 186 years old, because they're two of my best friends." "It was actually one of the most special things that's ever happened to me, like, spending all that time with them this summer," she added.

The backlash over GPT-5 shows people are getting hooked on specific AI models
The backlash over GPT-5 shows people are getting hooked on specific AI models

Business Insider

time2 hours ago

  • Business Insider

The backlash over GPT-5 shows people are getting hooked on specific AI models

OpenAI CEO Sam Altman's big GPT-5 announcement was drowned out by users clamoring to keep their access to older models. Less than 24 hours after OpenAI announced it would discontinue 4o, Altman and his team signaled a retreat. The fierce responses show that OpenAI's userbase has developed strong attachments to its various AI models, an achievement in and of itself, but one that poses a challenge to the company as it looks to convince people to shift to newer models. "If you have been following the GPT-5 rollout, one thing you might be noticing is how much of an attachment some people have to specific AI models," Altman wrote on X on OpenAI Sunday. "It feels different and stronger than the kinds of attachment people have had to previous kinds of technology (and so suddenly deprecating old models that users depended on in their workflows was a mistake)." Users have molded their ChatGPTs into quasi-therapists, life coaches, and friends. Altman previously said that one user said their GPT gave them more encouragement than a parent ever had. Other tech companies have annoyed and angered their users by changing hardware or interface. But Altman's rival CEOs never dealt with emotional bonds that mimic real life. The personality changes between models were particularly jarring for some. "GPT5 colder personality doesn't help either, it's just sad," one user wrote during the Reddit AMA. Another added after Altman said the older model was coming back for paid users, "Thanks, Sam—bringing back 4o is a fantastic first step. Please consider keeping it around long-term. Many of us rely on it every day, not just for accuracy or logic, but for the warmth newer models sometimes miss." Nick Turley, OpenAI's head of ChatGPT, said that the Reddit comments showed "just how polarized users could be." "It's not just change that is difficult for folks, it's also the fact that people can have such a strong feeling about the personality of a model," Turley told The Verge. Nicole DiNicola, VP of Marketing at Smartcat, said one of the mistakes OpenAI made was abruptly removing access to earlier models without warning. "The expectations have gotten so much higher for anything AI-related that it is much easier to be disappointed," DiNicola told Business Insider. Turley said the "level of passion" some users had for 4o led him to rethink some things. He also said that OpenAI announced before GPT-5 that users could select from four personalities for their chatbots: cynic, robot, listener, and nerd. "When I see people saying, 'Hey, this is my only and best friend,' that doesn't feel like the type of thing that I wanted to build into ChatGPT." Turley said. "That feels like a side effect, and it's therefore worth taking seriously and studying closely, and that's what we're doing." Harvey Hu, cofounder of General Agency AI, an applied research lab, said he found some of GPT-5's quick responses to be "slightly more stupid than 4o." It's not just functionality that can make users attached. "There may be a certain emotion, certain ways of prompting that you train yourself to learn, and if the certain model you got used gets sunsetted that could be definitely emotional thing for the users," Hu told Business Insider.

Drinkmate recalls over 100,000 carbonation bottles due to explosion risk
Drinkmate recalls over 100,000 carbonation bottles due to explosion risk

Washington Post

time3 hours ago

  • Washington Post

Drinkmate recalls over 100,000 carbonation bottles due to explosion risk

NEW YORK — More than 100,000 Drinkmate carbonation bottles are being recalled across the U.S. and Canada because they can explode during use, with several consumers reporting cuts and other impact injuries. According to a Thursday notice from the U.S. Consumer Product Safety Commission, the recall covers certain 'Drinkmate 1L Carbonation Bottles' sold individually or as part of the sparkling water maker's 'OmniFizz' starter kits. That includes about 106,200 bottles in the U.S., the safety regulator noted, as well as 5,000 in Canada. Drinkmate has received eight reports of these now-recalled bottles exploding during use in the U.S., the CPSC noted — four of which resulted in cuts, impact injuries and hearing damage. And per Health Canada , one additional case of a bottle shattering during use and causing some bruises has been reported in Canada. It wasn't immediately clear what's causing these bottles to explode — but Thursday's recall noted that the issue was limited to Drinkmate's 1-liter bottles with expiration dates between January 2026 and October 2026. The products have a clear polyethylene terephthalate body and plastic caps and bases in red, blue, white and black colors. In addition to Drinkmate's website, these bottles were sold by major retailers — including Walmart, Amazon, Target and Home Depot — between April 2023 and October 2024. Consumers in possession of the now-recalled products are urged to stop using them immediately — and contact Drinkmate for a free replacement. Those impacted can register for the recall and learn more on Drinkmate's website . To receive a free replacement bottle, you will need to fill out an online form and upload a picture of the product with the word 'recall' written on it in permanent marker, and throw it away per the recall's instructions. The Associated Press reached out to Michigan-based Drinkmate for further comment Thursday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store